Stockreport

Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million [Yahoo! Finance]

Perrigo Company plc Ordinary Shares  (PRGO) 
Last perrigo company plc ordinary shares earnings: 4/30 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: perrigo.investorroom.com
PDF Total Purchase Consideration of up to €275 Million, Consisting of €190 Million in Cash Upfront and up to €85 Million in Potential Earnouts; Based on 2023 Adjusted EBITD [Read more]